- Supported exchanges /
- KQ /
- 065650.KQ
Medifron DBT Co. Ltd (065650 KQ) stock market data APIs
Hyper Corporation Inc., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer's disease (AD) and neuropathic pain treatments, and AD diagnostics. Its products under development include TRPV1 Antagonist and TRPV1 Agonist for neuropathic pain; and anti-oligomerization of beta-amyloid, receptor for advanced glycation endproduct modulator, and early diagnosis kits for AD. The company wholesales and retails electronic devices, small home appliances, TVs, routers, and PC peripherals, such as gaming monitors, mouse, and wheels; keyboards; headsets; webcams; and sound bars, as well as provides online contents. In addition, it manufactures and supplies frozen and room temperature convenience food products, such as frozen sticky rice and fish cakes, tteokbokki sauce, and raw materials for sauce under the Memories of Elementary School Tteokbokki, Newtro, and K-TOWN brands. The company was formerly known as Medifron DBT Co., Ltd. and changed its name to Hyper Corporation Inc. in March 2024. Hyper Corporation Inc. was founded in 1997 and is headquartered in Seoul, South Korea.
Medifron DBT Co. Ltd Financial Data Overview
1181 | |
1183 | |
- | |
1187 | |
1131 | |
920-1697 | |
123 870 M | |
105 M | |
31 415 M | |
-179.2792 | |
1.339 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Medifron DBT Co. Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 31 415 M
- EBITDA -1 870 394 496
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Medifron DBT Co. Ltd Earnings via APIs
- Latest Release 2024-08-14
- EPS/Forecast NaN
Get Medifron DBT Co. Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: